Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Viral Specific T-cells (VSTs) for Treatment of SARS-CoV-2/COVID-19

NCT04406064 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT04406064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04406064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Viral Specific T-cells (VSTs) for Treatment of SARS-CoV-2/COVID-19
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2021
Completion date
June 30, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral infection